BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Assaf C, Waser N, Bagot M, He M, Li T, Dalal M, Gavini F, Trinchese F, Zomas A, Little M, Pimpinelli N, Ortiz-Romero PL, Illidge TM. Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries. Cancers (Basel) 2021;14:145. [PMID: 35008309 DOI: 10.3390/cancers14010145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Zeng S, Xu Z, Liang Q, Thakur A, Liu Y, Zhou S, Yan Y. The prognostic gene CRABP2 affects drug sensitivity by regulating docetaxel-induced apoptosis in breast invasive carcinoma: A pan-cancer analysis. Chem Biol Interact 2023;373:110372. [PMID: 36736488 DOI: 10.1016/j.cbi.2023.110372] [Reference Citation Analysis]
2 Wobser M, Goebeler M. Special Issue "Cutaneous Lymphomas". Cancers (Basel) 2023;15. [PMID: 36900273 DOI: 10.3390/cancers15051481] [Reference Citation Analysis]
3 Assaf C, Dobos G. Neue Therapieansätze und Kombinationstherapien bei kutanen T-Zell-Lymphomen. Dermatologie 2022;73:782-787. [DOI: 10.1007/s00105-022-05053-x] [Reference Citation Analysis]